THE ANGLO-US pharmaceuticals group, SmithKline Beecham, has linked up with Human Genome Services of the US to convert DNA coding data into commercial products, especially new drugs. Glaxo and Roche have also made similar forays in the race for a new range of drugs and diagnostic products, which are natural follow-ups to the worldwide project to decode the estimated 100,000 genes that make up the human "genome". The project is set to be completed in 10 years, much faster than initially estimated.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.